Skip To Main Content
Robert Micheletti on Muck Rack

Robert Micheletti

As seen in: Color Research & Application, Wiley Online Library, American Journal of Clinical Dermatology, JAMA (The Journal of the American Medical Association), JAMA Dermatology, JAMA: Journal of the American Medical Association, MDEdge, MDedge Dermatology, Journal of The American Academy of Dermatology (JAAD)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis From an International Cohort

|
By Robert Micheletti, William B Song, Brian Chu
| Wiley Online Library Verified
Dear Editor, Vasculitis is a group of rare, multisystem diseases which may involve the skin. Characterization of the frequency, type, and significance of cutaneous manifestations in various vasculitides is incomplete [1].
Open in Who Shared Issue with article?

Hospital Dermatology: Review of Research in 2023-2024

|
By Jenny Wei, Robert Micheletti
| MDedge Dermatology Verified
Inpatient consultative dermatology has advanced as a subspecialty and increasingly gained recognition in recent years. Since its founding in 2009, the Society of Dermatology Hospitalists has fostered research and education in hospital dermatology.
Open in Who Shared Issue with article?

Prophylaxis Against Pneumocystis Pneumonia

|
By Avrom S. Caplan, Christopher A. Mecoli, Robert Micheletti, Shiwei Zhou
| JAMA: Journal of the American Medical Association Verified
Prophylaxis Against Pneumocystis Pneumonia To the Editor A recent JAMA Insights article reviewed indications for Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised adults.1 The authors commented that patients receiving corticosteroids at doses equivalent to at least 20 mg/d of prednisone for at least 4 weeks who have an additional cause of immunosuppression should receive Pneumocystis pneumonia (PCP) prophylaxis.1 They also noted there is no consensus for when to initiate PCP...
Open in Who Shared Issue with article?
See all 19 articles